1. CNATUS Q2 Earnings: What Happened?

On August 14, 2025, CNATUS announced its Q2 earnings, reporting revenue of 17.3 billion KRW, operating profit of 0 KRW, and net profit of 2.1 billion KRW. While exceeding market expectations for revenue and net profit is positive, the stagnant operating profit raises concerns.

2. Behind the Surprise: Why These Results?

The revenue increase is attributed to a recovery from the previous quarter, while the net profit reflects non-operating factors such as increased financial income. However, the operating profit at 0 KRW indicates ongoing challenges in profitability improvement.

3. Impact on Investors: What Should You Do?

Short-term upward momentum is expected, but the weak operating profit poses a risk. Long-term investors should monitor the performance of new businesses, mask business recovery, and macroeconomic conditions. The success of the PLLA-based medical biomaterial business will be a crucial factor.

4. Investment Action Plan: A Wise Investor’s Choice

  • Short-term Investment: Consider a dip-buying strategy rather than chasing the stock.
  • Long-term Investment: Monitor the progress and concrete achievements of new businesses with caution.
  • Risk Management: Manage risks related to macroeconomic indicator changes, including interest rates and exchange rate fluctuations.